MAHAFFY PATRICK J 4

What Happened

• Patrick J. Mahaffy, a director of Medicus Pharma Ltd. (MDCX), received a derivative award on June 3, 2026: an option covering 50,000 shares. The Form 4 reports the transaction as an Award/Grant (code A) with a reported price of $0.00. This was a grant of equity (an option), not a purchase or sale.

Key Details

• Transaction date: June 3, 2026; Form 4 filed June 4, 2026 (timely).
• Transaction type/code: Award/Grant (A); derivative (option) for 50,000 shares; reported price $0.00.
• Shares owned after transaction: not specified in the filing.
• Footnote: The option was granted June 3, 2026 and is scheduled to vest quarterly in four equal installments over one year.
• Filing timeliness: filed next day — not marked late.

Context

• This is a grant of an option award that vests over a year; it is not an exercise or sale and does not itself involve immediate cash proceeds or a market sale. Grants are common compensation for executives and directors and do not directly signal buying/selling in the open market.